UK markets close in 7 hours 47 minutes

AstraZeneca PLC (AZN.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
10,232.00-58.00 (-0.56%)
As of 08:28AM GMT. Market open.
Full screen
Previous close10,290.00
Open10,236.00
Bid10,230.00 x 0
Ask10,232.00 x 0
Day's range10,204.00 - 10,248.00
52-week range9,461.00 - 12,392.00
Volume48,637
Avg. volume2,951,774
Market cap158.679B
Beta (5Y monthly)0.17
PE ratio (TTM)34.22
EPS (TTM)2.99
Earnings date25 Apr 2024
Forward dividend & yield2.28 (2.21%)
Ex-dividend date22 Feb 2024
1y target est122.07
  • Reuters

    UPDATE 2-AstraZeneca bets on new cancer treatments with $2 bln Fusion Pharma purchase

    AstraZeneca said on Tuesday it will buy clinical-stage biopharmaceutical company Fusion Pharmaceuticals Inc for about $2 billion in cash as the Anglo-Swedish drugmaker bets on next-generation cancer treatments. The deal is AstraZeneca's second this month after it agreed last week to buy Amolyt Pharma for $1.05 billion to shore up its rare disease portfolio. The drugmaker will pay $21 per Fusion share, a premium of more than 97% to the U.S.-listed company's closing price on Monday.

  • Reuters

    AstraZeneca bets on new cancer treatments with $2 billion Fusion Pharma purchase

    (Reuters) -AstraZeneca said on Tuesday it will buy clinical-stage biopharmaceutical company Fusion Pharmaceuticals Inc for about $2 billion in cash as the Anglo-Swedish drugmaker bets on next-generation cancer treatments. The deal is AstraZeneca's second this month after it agreed last week to buy Amolyt Pharma for $1.05 billion to shore up its rare disease portfolio. The drugmaker will pay $21 per Fusion share, a premium of more than 97% to the U.S.-listed company's closing price on Monday.

  • Zacks

    AstraZeneca PLC (AZN) Is a Trending Stock: Facts to Know Before Betting on It

    Astrazeneca (AZN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.